Comparison of Electron Spin Resonance Spectroscopy and Inductively-Coupled Plasma Optical Emission Spectroscopy for Biodistribution Analysis of Iron-Oxide Nanoparticles

被引:64
作者
Chertok, Beata [1 ]
Cole, Adam J. [1 ]
David, Allan E. [1 ,2 ]
Yang, Victor C. [1 ,3 ]
机构
[1] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA
[2] Ind Sci & Technol Network Inc, York, PA 17404 USA
[3] Tianjin Univ, Tianjin Key Lab Modern Drug Delivery & High Effic, Tianjin 300072, Peoples R China
关键词
Iron oxide nanoparticles; magnetic nanoparticle biodistribution; electron spin resonance spectroscopy; inductively coupled plasma optical emission spectroscopy; targeted drug delivery; magnetic targeting; MAGNETIC NANOPARTICLES; FE3O4; NANOPARTICLES; DRUG-DELIVERY; MRI; TUMORS; LIVER; EPR;
D O I
10.1021/mp900161h
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Magnetic nanoparticles (MNP) have been widely studied for use in targeted drug delivery. Analysis of MNP biodistribution is essential to evaluating the success of targeting strategies and the potential for off-target toxicity. This work compared the applicability of inductively coupled plasma optical emission spectroscopy (ICP-OES) and electron spin resonance (ESR) spectroscopy in assessing MNP biodistribution. Biodistribution was evaluated in 9L-glioma bearing rats administered with MNP (12-25 mg Fe/kg) under magnetic targeting. Ex vivo analysis of MNP in animal tissues was performed with both ICP-OES and ESR. A cryogenic method was developed to overcome the technical hurdle of loading tissue samples into ESR tubes. Comparison of results from the ICP-OES and ESR measurements revealed two distinct relationships for organs accumulating high or low levels of MNP. In organs with high MNP accumulation such as the liver and spleen, data were strongly correlated (r = 0.97, 0.94 for the liver and spleen, respectively), thus validating the equivalency of the two methods in this high concentration range (>1000 nmol Fe/g tissue). The two sets of measurements, however, differed significantly in organs with lower levels of MNP accumulation such as the brain, kidney, and the tumor. Whereas ESR resolved MNP to 10-55 nmol Fe/g tissue, ICP-OES failed to detect MNP because of masking by endogenous iron. These findings suggest that ESR coupled to cryogenic sample handling is more robust than ICP-OES, attaining better sensitivity in analyses. Such advantages render ESR the method of choice for accurate profiling of MNP biodistribution across tissues with high variability in nanoparticle accumulation.
引用
收藏
页码:375 / 385
页数:11
相关论文
共 40 条
[1]   Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting [J].
Alexiou, C ;
Arnold, W ;
Hulin, P ;
Klein, RJ ;
Renz, H ;
Parak, FG ;
Bergemann, C ;
Lübbe, AS .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2001, 225 (1-2) :187-193
[2]   Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent [J].
Bourrinet, P ;
Bengele, HH ;
Bonnemain, B ;
Dencausse, A ;
Idee, JM ;
Jacobs, PM ;
Lewis, JM .
INVESTIGATIVE RADIOLOGY, 2006, 41 (03) :313-324
[3]   Evaluation of tumoral enhancement by superparamagnetic iron oxide particles:: comparative studies with ferumoxtran and anionic iron oxide nanoparticles [J].
Brillet, PY ;
Gazeau, F ;
Luciani, A ;
Bessoud, B ;
Cuénod, CA ;
Siauve, N ;
Pons, JN ;
Poupon, J ;
Clément, O .
EUROPEAN RADIOLOGY, 2005, 15 (07) :1369-1377
[4]   Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors [J].
Chertok, Beata ;
Moffat, Bradford A. ;
David, Allan E. ;
Yu, Faquan ;
Bergemann, Christian ;
Ross, Brian D. ;
Yang, Victor C. .
BIOMATERIALS, 2008, 29 (04) :487-496
[5]   Recent advances in iron oxide nanocrystal technology for medical imaging [J].
Corot, Claire ;
Robert, Philippe ;
Idee, Jean-Marc ;
Port, Marc .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (14) :1471-1504
[6]   Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells [J].
Crichton, RR ;
Wilmet, S ;
Legssyer, R ;
Ward, RJ .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2002, 91 (01) :9-18
[7]   Magnetic nanoparticles for drug delivery [J].
Dobson, J .
DRUG DEVELOPMENT RESEARCH, 2006, 67 (01) :55-60
[8]   Kinetics of elimination and distribution in blood and liver of biocompatible ferrofluids based on Fe3O4 nanoparticles:: An EPR and XRF study [J].
Gamarra, L. F. ;
Pontuschka, W. M. ;
Amaro, E. ;
Costa-Filho, A. J. ;
Brito, G. E. S. ;
Vieira, E. D. ;
Carneiro, S. M. ;
Escriba, D. M. ;
Falleiros, A. M. F. ;
Salvador, V. L. .
MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS, 2008, 28 (04) :519-525
[9]   Magnetic nanoparticles for cancer therapy [J].
Goya, G. F. ;
Grazu, V. ;
Ibarra, M. R. .
CURRENT NANOSCIENCE, 2008, 4 (01) :1-16
[10]   Thermal ablation of tumors using magnetic nanoparticles - An in vivo feasibility study [J].
Hilger, I ;
Hiergeist, R ;
Hergt, R ;
Winnefeld, K ;
Schubert, H ;
Kaiser, WA .
INVESTIGATIVE RADIOLOGY, 2002, 37 (10) :580-586